dipyridamole has been researched along with digoxin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Gould, KL; Hamilton, GW; Narahara, KA; Ritchie, JL; Williams, DL; Yee, H | 1 |
| Carroll, TR; Morgan, RA; Mousa, SA | 1 |
| Aronson, JK; Bunch, C; Grahame-Smith, DG; Wood, AJ | 1 |
| Araki, Y; Fukuda, T; Furuno, K; Kawakami, Y | 1 |
| Felix, R; Hahn, N | 1 |
| Tejani, N | 1 |
| Becquemont, L; Brinkmann, U; Dubert, L; El-Morabet, H; Funck-Brentano, C; Jaillon, P; Kerb, R; Strabach, S; Trugnan, G; Verstuyft, C | 1 |
| Aytemiz, D; Fukayama, T; Fukushima, R; Hamabe, L; Huai-Che, H; Kim, S; Machida, N; Matsumoto, H; Suzuki, S; Tanaka, R; Yamane, Y; Yoshiyuki, R | 1 |
1 review(s) available for dipyridamole and digoxin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for dipyridamole and digoxin
| Article | Year |
|---|---|
A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole.
Topics: Adult; Digoxin; Dipyridamole; Erythrocyte Membrane; Humans; Lithium; Male; Middle Aged; Models, Biological; Spectrophotometry, Atomic | 1989 |
Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.
Topics: Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cardiotonic Agents; Cross-Over Studies; Cysteine; Digoxin; Dipyridamole; Enzyme Inhibitors; Female; Genes, MDR; Genotype; Humans; Male; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Reference Values; Threonine | 2003 |
14 other study(ies) available for dipyridamole and digoxin
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Myocardial imaging with thallium-201: effect of cardiac drugs on myocardial images and absolute tissue distribution.
Topics: Animals; Digoxin; Dipyridamole; Dogs; Furosemide; Heart; Myocardium; Propranolol; Radioisotopes; Radionuclide Imaging; Thallium; Tissue Distribution | 1978 |
Acute effects of commonly used drugs in the cardiac care unit on the myocardial extraction kinetics of 99mTc-Sestamibi.
Topics: Animals; Coronary Care Units; Coronary Disease; Digoxin; Dipyridamole; Drug Interactions; Guinea Pigs; Heart; Male; Myocardium; Organotechnetium Compounds; Swine; Swine, Miniature; Technetium Tc 99m Sestamibi; Verapamil | 1991 |
Determination of the onset of beta-methyl-digoxin action by potentiation of the adenosine response in guinea pigs.
Topics: Adenosine; Animals; Digoxin; Dipyridamole; Drug Synergism; Guinea Pigs; Heart; Heart Block; Intestinal Absorption; Male; Medigoxin; Rats; Rats, Inbred Strains; Time Factors | 1985 |
[Proceedings: Microcirculation and ventricular-wall function in the normal and partially ischemia-damaged myocardium under pharmacologic influence in animal experiment].
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Digoxin; Dipyridamole; Dogs; Heart; Ischemia; Isoproterenol; Microcirculation; Nitroglycerin; Papaverine | 1974 |
Anticoagulant therapy with cardiac valve prosthesis during pregnancy.
Topics: Adult; Anticoagulants; Digoxin; Dipyridamole; Female; Heart Valve Prosthesis; Heparin; Humans; Mitral Valve; Pregnancy; Pregnancy Complications, Cardiovascular; Quinidine; Rheumatic Heart Disease; Warfarin | 1973 |
Extreme tetralogy of Fallot in a dog.
Topics: Angiocardiography; Animals; Captopril; Digoxin; Dipyridamole; Dog Diseases; Dogs; Echocardiography; Electrocardiography; Female; Pulmonary Artery; Tetralogy of Fallot; Treatment Outcome | 2013 |